In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%
TB-500 upregulates vascular endothelial growth factor (VEGF) and related pro-angiogenic factors, promoting new blood vessel formation crucial to tissue repair
This will minimize your risk for unexpected reactions, that you might then blame on the B12 itself
The result: severe water retention, numbness and tingling in the hands (carpal tunnel symptoms from excessive GH), facial flushing, and paradoxically reduced GH output as the pituitary downregulates its response
Angiogenesis, or new blood vessel formation, has been consistently observed in animal models, which improves nutrient delivery and accelerates healing in injured tissues